Sector Report

Power of sector investing

Send me real-time posts from this site at my email

7 Biotech And Healthcare Picks For 2017 From Cantor Fitzgerald

After a forgettable year for biotech and healthcare stocks, 2017 has dawned with new hopes. Although the Democratic threat on a clamp down on price gouging hit the space for much of 2016 amid the presidential election campaign, the election of Republican Donald Trump initially generated some optimism. However, Trump has since sent out a veiled threat of being uncomfortable with higher drug prices.

7 In Focus

Against this backdrop, Cantor Fitzgerald initiated coverage of the following biotech and healthcare stocks at Overweight, making these its top picks in the space for 2017:

  • athenahealth, Inc ATHN: price target of $135 (18 percent upside from current levels).
  • Cerner Corporation CERN: price target of $66 (34 percent upside from current levels).
  • eHealth, Inc. EHTH: price target of $15 (48 percent upside from current levels).
  • Evolent Health Inc EVH: price target of $26 (74 percent upside from current levels).
  • NantHealth Inc NH: price target of $17 (73 percent upside from current levels).
  • Omnicell, Inc. OMCL: price target of $40 (21 percent upside from current levels).
  • Teladoc Inc TDOC: price target of $25 (over 50 percent upside from current levels).

via

Cancel